abstract |
The present invention relates essentially to a solid form of 3- (6- (1- (2,2-difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido) -3-methylpyridin-2-yl) benzoic acid (Compound 1, Solvate Form A and Compound 1, HCl Salt Form A), methods for making such forms, pharmaceutical compositions thereof, and methods of treatment thereof. |